Abbott Laboratories : ABT

All Abbott Laboratories Articles

311 Articles

Douglas A. McIntyre | Mar 29, 2010 at 3:55 AM EDT

24/7 Wall St.’s Corporate Power Rankings (Week 12)

These are 24/7 Wall St.’s Corporate Power Rankings for Week 12.

Douglas A. McIntyre | Mar 21, 2010 at 7:12 PM EDT

24/7 Wall St.’s Corporate Power Rankings (Week 11)

The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined by earnings, analyst…

Douglas A. McIntyre | Mar 15, 2010 at 10:31 AM EDT

No Signs Of Intelligent Life At Boston Scientific

Virtually nothing has gone right at Boston Scientific (BSX) since it bought rival Guidant in a bidding war with Johnson & Johnson (JNJ)…

Douglas A. McIntyre | Mar 15, 2010 at 5:10 AM EDT

24/7 Wall St.’s Corporate Power Rankings (Week 10)

The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined by earnings, analyst…

Douglas A. McIntyre | Mar 15, 2010 at 2:58 AM EDT

Media Digest 3/15/2010 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters: The Senate reform bill gives the Fed broader powers. Reuters: Google (GOOG) says it is still talking to China,…

Jon C. Ogg | Mar 12, 2010 at 8:38 AM EST

Top 10 Analyst Upgrades and Downgrades (ABT, ARO, BIIB, CELG, CADC, FACT, HBC, LMNX, EDU, SGI)

These are this Friday’s top analyst upgrades, downgrades, and initiations seen from Wall Street morning research calls: Abbott Laboratories (NYSE:…

Douglas A. McIntyre | Mar 10, 2010 at 11:25 AM EST

The Below Average CEO: J. Raymond Elliott, Boston Scientific

Average: “an estimation of or approximation to an arithmetic mean”–Webster The smartest move that J. Raymond Elliot made in his…

Douglas A. McIntyre | Mar 8, 2010 at 4:04 AM EST

24/7 Wall St.’s Corporate Power Rankings (Week 9)

The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined by earnings, analyst…

Douglas A. McIntyre | Mar 1, 2010 at 5:08 AM EST

24/7 Wall St.’s Corporate Power Rankings (Week 8)

The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined by earnings, analyst rankings,…

Douglas A. McIntyre | Feb 26, 2010 at 3:54 AM EST

The Drug Lords, The Men Who Run The Global Phamaceutical Industry

There are twelve major pharmaceutical firms that dominate this industry worldwide. Their combined market value is over $1 trillion with total…

Douglas A. McIntyre | Feb 22, 2010 at 11:43 AM EST

24/7 Wall St.’s Corporate Power Rankings (Week 7)

The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined by earnings, analyst…

Douglas A. McIntyre | Feb 16, 2010 at 4:01 AM EST

24/7 Wall St.’s Corporate Power Rankings (Week 6)

The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined by earnings, analyst…

Douglas A. McIntyre | Feb 8, 2010 at 4:09 AM EST

24/7 Wall St.’s Corporate Power Rankings (Week 5)

The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined by earnings, analyst rankings,…

Douglas A. McIntyre | Feb 1, 2010 at 4:04 AM EST

24/7 Wall St.’s Corporate Power Rankings (Week 4)

The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined by earnings, analyst…

Douglas A. McIntyre | Jan 25, 2010 at 6:09 AM EST

24/7 Wall St.’s Corporate Power Rankings (Week 3)

The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined be earnings, analyst…

1 … 16 17 18 19 20 21

Abbott Laboratories : ABT

All Abbott Laboratories Articles

24/7 Wall St.’s Corporate Power Rankings (Week 12)

24/7 Wall St.’s Corporate Power Rankings (Week 11)

No Signs Of Intelligent Life At Boston Scientific

24/7 Wall St.’s Corporate Power Rankings (Week 10)

Media Digest 3/15/2010 Reuters, WSJ, NYTimes, FT, Bloomberg

Top 10 Analyst Upgrades and Downgrades (ABT, ARO, BIIB, CELG, CADC, FACT, HBC, LMNX, EDU, SGI)

The Below Average CEO: J. Raymond Elliott, Boston Scientific

24/7 Wall St.’s Corporate Power Rankings (Week 9)

24/7 Wall St.’s Corporate Power Rankings (Week 8)

The Drug Lords, The Men Who Run The Global Phamaceutical Industry

24/7 Wall St.’s Corporate Power Rankings (Week 7)

24/7 Wall St.’s Corporate Power Rankings (Week 6)

24/7 Wall St.’s Corporate Power Rankings (Week 5)

24/7 Wall St.’s Corporate Power Rankings (Week 4)

24/7 Wall St.’s Corporate Power Rankings (Week 3)

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Abbott Laboratories : ABT

All Abbott Laboratories Articles

24/7 Wall St.’s Corporate Power Rankings (Week 12)

24/7 Wall St.’s Corporate Power Rankings (Week 11)

No Signs Of Intelligent Life At Boston Scientific

24/7 Wall St.’s Corporate Power Rankings (Week 10)

Media Digest 3/15/2010 Reuters, WSJ, NYTimes, FT, Bloomberg

Top 10 Analyst Upgrades and Downgrades (ABT, ARO, BIIB, CELG, CADC, FACT, HBC, LMNX, EDU, SGI)

The Below Average CEO: J. Raymond Elliott, Boston Scientific

24/7 Wall St.’s Corporate Power Rankings (Week 9)

24/7 Wall St.’s Corporate Power Rankings (Week 8)

The Drug Lords, The Men Who Run The Global Phamaceutical Industry

24/7 Wall St.’s Corporate Power Rankings (Week 7)

24/7 Wall St.’s Corporate Power Rankings (Week 6)

24/7 Wall St.’s Corporate Power Rankings (Week 5)

24/7 Wall St.’s Corporate Power Rankings (Week 4)

24/7 Wall St.’s Corporate Power Rankings (Week 3)

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026